Debora Collotta, and Massimo Collino. “NLRP3 Inflammasome Signaling Platform As New Pharmacological Target for Metaflammation”. Diabetes Research 3, no. 1 (December 16, 2016): e1-e3. Accessed July 28, 2026. https://openventio.us/index.php/DR/article/view/1635.